| 455 |
Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced impeded craniofacial development |
Prarthana Shankar |
BY-SA |
18: Activation, AhR
|
2 AOs
|
WPHA/WNT Endorsed |
1.27 |
| 456 |
Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced cardiovascular toxicity |
Prarthana Shankar |
BY-SA |
18: Activation, AhR
|
947: Increase, Early Life Stage Mortality
|
WPHA/WNT Endorsed |
1.27 |
| 442 |
Binding to voltage gate sodium channels during development leads to cognitive impairment |
Iris Mangas |
BY-SA |
1353: Binding to voltage-gated sodium channel
|
402: Cognitive function, decreased
|
WPHA/WNT Endorsed |
1.91 |
| 376 |
Androgen receptor agonism leading to male-biased sex ratio |
Dan Villeneuve |
BY-SA |
25: Agonism, Androgen receptor
|
360: Decrease, Population growth rate
|
WPHA/WNT Endorsed |
1.12 |
| 346 |
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation |
Kelvin Santana Rodriguez |
BY-SA |
36: Inhibition, Aromatase
|
360: Decrease, Population growth rate
|
WPHA/WNT Endorsed |
1.12 |
| 360 |
Chitin synthase 1 inhibition leading to mortality |
Simon Schmid |
BY-SA |
1522: Inhibition, Chitin synthase 1
|
350: Increase, Mortality
|
WPHA/WNT Endorsed |
1.94 |
| 296 |
Oxidative DNA damage leading to chromosomal aberrations and mutations |
Carole Yauk |
BY-SA |
1634: Increase, Oxidative DNA damage
|
2 AOs
|
WPHA/WNT Endorsed |
1.76 |
| 277 |
Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response |
Takao Ashikaga |
BY-SA |
1700: Impaired IL-1R1 signaling in T cell
|
984: Impairment, T-cell dependent antibody response
|
WPHA/WNT Endorsed |
1.48 |
| 263 |
Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation |
You Song |
BY-SA |
1446: Decrease, Coupling of oxidative phosphorylation
|
1521: Decrease, Growth
|
WPHA/WNT Endorsed |
1.92 |
| 272 |
Deposition of energy leading to lung cancer |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
1556: Increase, lung cancer
|
WPHA/WNT Endorsed |
1.56 |
| 3 |
Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits |
Andrea Terron |
BY-SA |
888: Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)
|
896: Parkinsonian motor deficits
|
WPHA/WNT Endorsed |
1.33 |
| 6 |
Antagonist binding to PPARα leading to body-weight loss |
Kurt A. Gust |
BY-SA |
998: Binding of antagonist, PPAR alpha
|
864: Decreased, Body Weight
|
WPHA/WNT Endorsed |
2.3 |
| 483 |
Deposition of Energy Leading to Learning and Memory Impairment |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
341: Impairment, Learning and memory
|
WPHA/WNT Endorsed |
1.89 |
| 470 |
Deposition of energy leads to abnormal vascular remodeling |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2069: Occurrence, Abnormal Vascular Remodeling
|
WPHA/WNT Endorsed |
1.89 |
| 478 |
Deposition of energy leading to occurrence of cataracts |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2083: Occurrence of Cataracts
|
WPHA/WNT Endorsed |
1.89 |
| 482 |
Deposition of energy leading to occurrence of bone loss |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2091: Occurrence, Bone Loss
|
WPHA/WNT Endorsed |
1.89 |
| 220 |
Cyp2E1 Activation Leading to Liver Cancer |
Francina Webster |
BY-SA |
1391: Activation of Cyp2E1
|
1395: Liver Cancer
|
WPHA/WNT Endorsed |
1.24 |
| 155 |
Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation |
Dries Knapen |
BY-SA |
1002: Inhibition, Deiodinase 2
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 156 |
Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation |
Dries Knapen |
BY-SA |
1002: Inhibition, Deiodinase 2
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 157 |
Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation |
Dries Knapen |
BY-SA |
1009: Inhibition, Deiodinase 1
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 158 |
Deiodinase 1 inhibition leading to increased mortality via reduced anterior swim bladder inflation |
Dries Knapen |
BY-SA |
1009: Inhibition, Deiodinase 1
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 159 |
Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation |
Dries Knapen |
BY-SA |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 173 |
Substance interaction with the pulmonary resident cell membrane components leading to pulmonary fibrosis |
Sabina Halappanavar |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1458: Pulmonary fibrosis
|
WPHA/WNT Endorsed |
1.32 |
| 54 |
Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment |
Anna Price |
BY-SA |
424: Inhibition, Na+/I- symporter (NIS)
|
341: Impairment, Learning and memory
|
WPHA/WNT Endorsed |
1.28 |
| 150 |
Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF |
Amani Farhat |
BY-SA |
18: Activation, AhR
|
947: Increase, Early Life Stage Mortality
|
WPHA/WNT Endorsed |
1.7 |